Antheia
United States · Biotech · Industrial tech · Healthtech
Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients.
Biosynthetic ingredients for pharmaceutical manufacturers
Antheia produces key starting materials and active pharmaceutical ingredients used to make medicines. Its customers are pharmaceutical companies seeking a reliable supply of complex ingredients that have traditionally depended on agricultural sources and lengthy production cycles.
Manufacturing through controlled fermentation
The company uses biosynthesis in contained fermentation environments to manufacture ingredients at commercial scale. This approach is intended to make output more predictable and less dependent on changes in crop yields, weather and pests. Its platform supports both the supply of existing essential medicines and development of additional pharmaceutical ingredients.
Funding history
2 rounds · 2 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| BioMaP project agreement expansion | $9M | Participants not disclosed | |
| Series C second close | $24M | America's Frontier Fund — LeadATHOS KG — LeadGlobal Health Investment Corporation (GHIC) — Participant |